Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.
作者信息
Vakhshoorzadeh Jasmine, Lui Justin K, Sangani Ruchika A, Trojanowski Marcin A, Bujor Andreea M, LaValley Michael P, Klings Elizabeth S
机构信息
Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Department of Medicine, Boston University School of Medicine, Boston, MA, USA; The Pulmonary Center, Boston University School of Medicine, Boston, MA, USA.
出版信息
Respir Med. 2023 Sep;216:107333. doi: 10.1016/j.rmed.2023.107333. Epub 2023 Jun 17.
Abstract
摘要
相似文献
1
Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.系统性硬化症相关肺动脉高压中的肺气肿和间质性肺疾病
Respir Med. 2023 Sep;216:107333. doi: 10.1016/j.rmed.2023.107333. Epub 2023 Jun 17.
2
Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.硬皮病相关肺疾病中的合并性肺纤维化和肺气肿对肺生理学和肺动脉高压筛查有重大的混杂影响。
Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.
3
Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report.特发性肺气肿在非吸烟的硬皮病相关间质性肺炎患者中的形成：病例报告。
Pan Afr Med J. 2022 Aug 19;42:295. doi: 10.11604/pamj.2022.42.295.29442. eCollection 2022.
4
Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?硬皮病相关性间质性肺疾病合并气肿性改变：血管病变的潜在作用？
BMC Pulm Med. 2018 Jan 30;18(1):25. doi: 10.1186/s12890-018-0591-y.
5
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis.系统性硬化症中不伴有肺纤维化的肺气肿。
Respir Med. 2019 Nov-Dec;160:105816. doi: 10.1016/j.rmed.2019.105816. Epub 2019 Nov 9.
6
Assessment and management of scleroderma lung disease.硬皮病肺病的评估与管理
Curr Opin Rheumatol. 1999 Nov;11(6):508-13.
7
Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise.
Eur Respir J. 1997 Sep;10(9):2055-60. doi: 10.1183/09031936.97.10092055.
8
Combined pulmonary fibrosis and emphysema in systemic sclerosis: A syndrome associated with heavy morbidity and mortality.系统性硬皮病合并肺纤维化和肺气肿：一种与高发病率和死亡率相关的综合征。
Semin Arthritis Rheum. 2019 Aug;49(1):98-104. doi: 10.1016/j.semarthrit.2018.10.011. Epub 2018 Oct 13.
9
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.系统性硬化症中的肺动脉高压：诊断途径与治疗方法
Ann Rheum Dis. 2005 Jun;64(6):804-7. doi: 10.1136/ard.2004.026427.
10
Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.间质性肺疾病会增加合并肺动脉高压的系统性硬化症患者的死亡率，而不影响血流动力学和运动能力。
Clin Rheumatol. 2017 Feb;36(2):381-390. doi: 10.1007/s10067-016-3504-6. Epub 2016 Dec 27.
本文引用的文献
1
Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity.系统性硬化症肺部表现的临床特征与预后：肺动脉高压和间质性肺疾病严重程度的影响
Pulm Circ. 2022 Oct 1;12(4):e12117. doi: 10.1002/pul2.12117. eCollection 2022 Oct.
2
Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis.特发性肺纤维化合并肺气肿对结缔组织疾病和系统性硬化症患者的影响：系统评价和荟萃分析。
Arthritis Res Ther. 2021 Apr 6;23(1):100. doi: 10.1186/s13075-021-02494-y.
3
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压与系统性硬化症相关肺动脉高压患者治疗后血流动力学反应及结局比较：特发性肺纤维化相关肺动脉高压预后因素研究数据。
Arthritis Rheumatol. 2021 Feb;73(2):295-304. doi: 10.1002/art.41512. Epub 2020 Dec 29.
4
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.免疫抑制治疗与系统性硬化症中轻度间质性肺疾病病程的关联
Rheumatology (Oxford). 2020 May 1;59(5):1108-1117. doi: 10.1093/rheumatology/kez407.
5
Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis.系统性硬化症相关的肺纤维化合并肺气肿的总体死亡率。
RMD Open. 2019 Feb 14;5(1):e000820. doi: 10.1136/rmdopen-2018-000820. eCollection 2019.
6
FEV1 and FVC predict all-cause mortality independent of cardiac function - Results from the population-based Gutenberg Health Study.第一秒用力呼气容积（FEV1）和用力肺活量（FVC）可独立于心脏功能预测全因死亡率——基于人群的古登堡健康研究结果。
Int J Cardiol. 2017 May 1;234:64-68. doi: 10.1016/j.ijcard.2017.02.012. Epub 2017 Feb 3.
7
Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.与间质性肺疾病相关的系统性硬化症相关性肺动脉高压：肺动脉高压治疗的影响
Arthritis Rheum. 2011 Aug;63(8):2456-64. doi: 10.1002/art.30423.
8
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.硬皮病谱系疾病相关肺动脉高压的生存情况：间质性肺疾病的影响
Arthritis Rheum. 2009 Feb;60(2):569-77. doi: 10.1002/art.24267.
9
Changes in causes of death in systemic sclerosis, 1972-2002.1972年至2002年系统性硬化症的死因变化
Ann Rheum Dis. 2007 Jul;66(7):940-4. doi: 10.1136/ard.2006.066068. Epub 2007 Feb 28.
10
Pulmonary function testing in interstitial lung diseases.间质性肺疾病的肺功能测试
Respiration. 2004 May-Jun;71(3):209-13. doi: 10.1159/000077416.
Zotero 插件